Paragon 28, Inc. (FNA)

USD 10.04

(-3.09%)

Revenue Summary of Paragon 28, Inc.

  • Paragon 28, Inc.'s latest annual revenue in 2023 was 216.38 Million USD , up 19.3% from previous year.
  • Paragon 28, Inc.'s latest quarterly revenue in 2024 Q2 was 61.01 Million USD , down -0.11% from previous quarter.
  • Paragon 28, Inc. reported a annual revenue of 181.38 Million USD in annual revenue 2022, up 23.0% from previous year.
  • Paragon 28, Inc. reported a annual revenue of 147.46 Million USD in annual revenue 2021, up 32.87% from previous year.
  • Paragon 28, Inc. reported a quarterly revenue of 61.08 Million USD for 2024 Q1, up 0.86% from previous quarter.
  • Paragon 28, Inc. reported a quarterly revenue of 52.78 Million USD for 2023 Q3, up 3.48% from previous quarter.

Annual Revenue Chart of Paragon 28, Inc. (2023 - 2019)

Historical Annual Revenue of Paragon 28, Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 216.38 Million USD 19.3%
2022 181.38 Million USD 23.0%
2021 147.46 Million USD 32.87%
2020 110.98 Million USD 4.42%
2019 106.28 Million USD 0.0%

Peer Revenue Comparison of Paragon 28, Inc.

Name Revenue Revenue Difference
Abbott Laboratories 40.1 Billion USD 99.46%
Allurion Technologies Inc. 53.46 Million USD -304.715%
Artivion, Inc. 354 Million USD 38.874%
Avanos Medical, Inc. 673.3 Million USD 67.861%
Butterfly Network, Inc. 65.9 Million USD -228.36%
Butterfly Network, Inc. 65.9 Million USD -228.36%
Bio-Rad Laboratories, Inc. 2.67 Billion USD 91.899%
Boston Scientific Corporation 14.24 Billion USD 98.48%
Perspective Therapeutics, Inc. 7.1 Million USD -2946.016%
CONMED Corporation 1.24 Billion USD 82.563%
Edwards Lifesciences Corporation 6 Billion USD 96.396%
Glaukos Corporation 314.71 Million USD 31.242%
Globus Medical, Inc. 1.56 Billion USD 86.204%
Inspire Medical Systems, Inc. 624.79 Million USD 65.367%
Integer Holdings Corporation 1.59 Billion USD 86.448%
Medtronic plc 32.36 Billion USD 99.331%
Nevro Corp. 425.17 Million USD 49.106%
Owlet, Inc. 54.01 Million USD -300.646%
Penumbra, Inc. 1.05 Billion USD 79.557%
Vicarious Surgical Inc. - USD -Infinity%
Smith & Nephew plc 5.54 Billion USD 96.1%
Sonendo, Inc. 43.86 Million USD -393.307%
STERIS plc 5.13 Billion USD 95.789%
Stryker Corporation 20.49 Billion USD 98.944%
Vapotherm, Inc. 68.66 Million USD -215.119%
Zimmer Biomet Holdings, Inc. 7.39 Billion USD 97.074%